FibroBiologics, Inc. (Nasdaq:FBLG)

Health Care/Life Sciences • Biotechnology

CIK 1958777

Company

FibroBiologics, Inc. engages in the development and commercialization of cell therapies. It focuses on treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The firm’s product pipeline includes CybroCell, CYMS101, CYWC628, TCB190, and CYTER915. The company was founded by Peter O’Heeron on April 8, 2021 and is headquartered in Houston, TX.

Address
455 East Medical Center Boulevard
Suite 300
Houston, Texas 77598

Employees
10

Stock Info

Close
$1.1700

Day Range
1.1700 - 1.2900

52 Week Range
0.9837 - 13.5900

Average volume
277.43K

Short Interest
1.95M (02/14/25)

% of Float Shorted
6.98%

Market Cap
$42.6M

Revenue
N/A

Net Income
-$16.49M

2020 Sales Growth
N/A

Rev. per Employee
N/A

P/E Ratio
N/A

EPS
-$0.5902

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

Chairman & Chief Executive Officer
Peter O'Heeron

Independent Director
Matthew W. Link

Independent Director
Victoria Niklas

Independent Director
Richard C. Cilento Jr.

Independent Director
Stacy A. Coen

SEC filings

Date	Form	Event
20 Dec, 2024	8-K
9 Dec, 2024	4
5 Dec, 2024	4
12 Nov, 2024	10-Q
29 Oct, 2024	8-K
24 Sep, 2024	8-K
28 Aug, 2024	8-K
27 Aug, 2024	4
27 Aug, 2024	4
27 Aug, 2024	8-K
27 Aug, 2024	4
27 Aug, 2024	4
27 Aug, 2024	4
14 Aug, 2024	EFFECT
13 Aug, 2024	3/A
13 Aug, 2024	3/A
13 Aug, 2024	3/A
13 Aug, 2024	POS AM
13 Aug, 2024	3/A
13 Aug, 2024	3/A
13 Aug, 2024	3/A
12 Aug, 2024	3/A
12 Aug, 2024	3/A
12 Aug, 2024	4
12 Aug, 2024	4
7 Aug, 2024	10-Q
8 Jul, 2024	DEF 14A
8 Jul, 2024	ARS
8 Jul, 2024	DEFA14A
27 Jun, 2024	8-K
27 Jun, 2024	PRE 14A
26 Jun, 2024	424B4
25 Jun, 2024	EFFECT
21 Jun, 2024	CORRESP
21 Jun, 2024	CORRESP
18 Jun, 2024	S-1
18 Jun, 2024	CORRESP
17 Jun, 2024	UPLOAD
10 Jun, 2024	DRS
6 Jun, 2024	RW
4 Jun, 2024	S-1/A
15 May, 2024	S-1/A
15 May, 2024	S-8
14 May, 2024	10-Q
26 Apr, 2024	S-1
26 Apr, 2024	8-K
12 Apr, 2024	DRS
28 Mar, 2024	424B4
28 Mar, 2024	EFFECT
27 Mar, 2024	CORRESP
26 Mar, 2024	CORRESP
26 Mar, 2024	S-1/A
25 Mar, 2024	UPLOAD
15 Mar, 2024	CORRESP
15 Mar, 2024	S-1/A
8 Mar, 2024	4
6 Mar, 2024	3
29 Feb, 2024	10-K
26 Feb, 2024	UPLOAD
20 Feb, 2024	8-K
15 Feb, 2024	3
14 Feb, 2024	8-K
13 Feb, 2024	3
13 Feb, 2024	3
12 Feb, 2024	S-1
8 Feb, 2024	3
8 Feb, 2024	8-K
8 Feb, 2024	3
7 Feb, 2024	3
7 Feb, 2024	3
7 Feb, 2024	3
6 Feb, 2024	8-K
2 Feb, 2024	8-K
31 Jan, 2024	424B4	IPO completed
30 Jan, 2024	CERT
24 Jan, 2024	S-1/A
24 Jan, 2024	EFFECT
24 Jan, 2024	S-1/A
24 Jan, 2024	8-A12B
22 Jan, 2024	CORRESP
22 Jan, 2024	S-1/A
16 Jan, 2024	CORRESP
12 Jan, 2024	S-1/A
14 Dec, 2023	FWP
7 Dec, 2023	S-1/A
4 Dec, 2023	S-1/A
30 Nov, 2023	S-1/A
28 Nov, 2023	S-1/A
7 Nov, 2023	CORRESP
7 Nov, 2023	S-1
27 Oct, 2023	UPLOAD
13 Oct, 2023	DRS/A
13 Oct, 2023	DRSLTR
11 Sep, 2023	UPLOAD
16 Aug, 2023	DRSLTR
16 Aug, 2023	DRS/A
23 Jun, 2023	UPLOAD
18 May, 2023	DRS
1 May, 2023	C-AR
11 Apr, 2023	C-U
29 Mar, 2023	C/A
10 Feb, 2023	C/A
31 Jan, 2023	C

Last update:2025-03-06 12:07:40.216693

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.